Newsroom

Company news

Business
04 November 2020

Alvotech and Cipla partner to ensure access to biosimilars in South Africa

Business
27 October 2020

Alvotech announces private placement financing

Business
22 September 2020

Alvotech and DKSH extend partnership in Asia

Business
05 August 2020

Alvotech and Teva announce strategic partnership to collaborate in the U.S. biosimilar market

People
18 May 2020

Tanya Zharov joins Alvotech as Deputy CEO

Business
12 May 2020

Alvotech announces positive top-line results for two comparative studies.

Business
05 May 2020

Alvotech and Alvogen launch new B2B business brand

Business
24 March 2020

Alvotech and DKSH partner to bring key biosimilar to Asia

Business
24 March 2020

Delivering on our promise during the Coronavirus Pandemic

Business
14 January 2020

Alvotech and JAMP Pharma enter into an exclusive partnership

Business
13 November 2019

Alvotech at CPhI 2019

Business
06 November 2019

Alvotech and Stada agree on strategic biosimilar partnership

Business
04 November 2019

Yas Holding invests in Alvotech and agrees on a strategic partnership for biosimilar candidates

People
30 September 2019

Alvotech appoints new Chief Scientific Officer

Business
13 September 2019

Alvotech is warming up for CPhI 2019 in Frankfurt

Business
27 August 2019

Alvotech and Prestige Biopharma announce new manufacturing partnership

Business
29 July 2019

Alvotech and Cipla gulf into a partnership

Business
15 July 2019

Alvotech completes enrollment of phase III study involving biosimilar version of Humira®

Business
03 June 2019

Alvotech and Abdi Ibrahim enter into an exclusive partnership

People
09 May 2019

Mark Levick appointed CEO of Alvotech

Business
09 April 2019

Alvotech and Fuji Pharma announce agreement

Media Contact

Elisabet Hjaltadottir

Corporate Marketing & Communication